FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
Go back to FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study| AZTECA ACQUISITION CORP (NASDAQ: AZTA) | Delayed: 30.82 -0.51 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.33 | 52 Week High | $10.45 | |||
| Open | $30.82 | 52 Week Low | $9.73 | |||
| Day High | $31.66 | P/E | 99.42 | |||
| Day Low | $30.66 | EPS | $0.31 | |||
| Volume | 1,159,910 | |||||
| (NASDAQ: OLK) | Delayed: 26.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.08 | 52 Week High | $ | |||
| Open | $26.08 | 52 Week Low | $ | |||
| Day High | $26.08 | P/E | N/A | |||
| Day Low | $26.08 | EPS | $ | |||
| Volume | 17,582 | |||||
